BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 11433525)

  • 1. Amplification of Mycn, Ddx1, Rrm2, and Odc1 in rat uterine endometrial carcinomas.
    Karlsson A ; Helou K; Walentinsson A; Hedrich HJ; Szpirer C; Levan G
    Genes Chromosomes Cancer; 2001 Aug; 31(4):345-56. PubMed ID: 11433525
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Independent amplification of two gene clusters on chromosome 4 in rat endometrial cancer: identification and molecular characterization.
    Walentinsson A; Helou K; Wallenius V; Hedrich HJ; Szpirer C; Levan G
    Cancer Res; 2001 Nov; 61(22):8263-73. PubMed ID: 11719459
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oncogene amplification in the proximal part of chromosome 6 in rat endometrial adenocarcinoma as revealed by combined BAC/PAC FISH, chromosome painting, zoo-FISH, and allelotyping.
    Adamovic T; Trossö F; Roshani L; Andersson L; Petersen G; Rajaei S; Helou K; Levan G
    Genes Chromosomes Cancer; 2005 Oct; 44(2):139-53. PubMed ID: 15942940
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Investigation of co-amplification of the candidate genes ornithine decarboxylase, ribonucleotide reductase, syndecan-1 and a DEAD box gene, DDX1, with N-myc in neuroblastoma. United Kingdom Children's Cancer Study Group.
    George RE; Kenyon RM; McGuckin AG; Malcolm AJ; Pearson AD; Lunec J
    Oncogene; 1996 Apr; 12(7):1583-7. PubMed ID: 8622876
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The DDX1 gene maps within 400 kbp 5' to MYCN and is frequently coamplified in human neuroblastoma.
    Amler LC; Schürmann J; Schwab M
    Genes Chromosomes Cancer; 1996 Feb; 15(2):134-7. PubMed ID: 8834178
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Physical mapping of the DDX1 gene to 340 kb 5' of MYCN.
    Kuroda H; White PS; Sulman EP; Manohar CF; Reiter JL; Cohn SL; Brodeur GM
    Oncogene; 1996 Oct; 13(7):1561-5. PubMed ID: 8875996
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amplification of a DEAD box gene (DDX1) with the MYCN gene in neuroblastomas as a result of cosegregation of sequences flanking the MYCN locus.
    Noguchi T; Akiyama K; Yokoyama M; Kanda N; Matsunaga T; Nishi Y
    Genes Chromosomes Cancer; 1996 Feb; 15(2):129-33. PubMed ID: 8834177
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Co-amplification of MYCN and a DEAD box gene (DDX1) in primary neuroblastoma.
    Squire JA; Thorner PS; Weitzman S; Maggi JD; Dirks P; Doyle J; Hale M; Godbout R
    Oncogene; 1995 Apr; 10(7):1417-22. PubMed ID: 7731693
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytogenetic aberrations in spontaneous endometrial adenocarcinomas in the BDII rat model as revealed by chromosome banding and comparative genome hybridization.
    Hamta A; Adamovic T; Heloua K; Levan G
    Cancer Genet Cytogenet; 2005 Jun; 159(2):123-8. PubMed ID: 15899383
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two-dimensional DNA electrophoresis identifies novel CpG islands frequently coamplified with MYCN in neuroblastoma.
    Wimmer K; Zhu XX; Lamb BJ; Kuick R; Ambros P; Kovar H; Thoraval D; Elkahloun A; Meltzer P; Hanash SM
    Med Pediatr Oncol; 2001 Jan; 36(1):75-9. PubMed ID: 11464910
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of candidate gene co-amplification with MYCN in neuroblastoma.
    George RE; Kenyon R; McGuckin AG; Kohl N; Kogner P; Christiansen H; Pearson AD; Lunec J
    Eur J Cancer; 1997 Oct; 33(12):2037-42. PubMed ID: 9516849
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amplification and overexpression of the hepatocyte growth factor receptor (HGFR/MET) in rat DMBA sarcomas.
    Helou K; Wallenius V; Qiu Y; Ohman F; Ståhl F; Klinga-Levan K; Kindblom LG; Mandahl N; Jansson JO; Levan G
    Oncogene; 1999 May; 18(21):3226-34. PubMed ID: 10359528
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coamplification of DDX1 correlates with an improved survival probability in children with MYCN-amplified human neuroblastoma.
    Weber A; Imisch P; Bergmann E; Christiansen H
    J Clin Oncol; 2004 Jul; 22(13):2681-90. PubMed ID: 15226335
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relational mapping of MYCN and DDXI in band 2p24 and analysis of amplicon arrays in double minute chromosomes and homogeneously staining regions by use of free chromatin FISH.
    Pandita A; Godbout R; Zielenska M; Thorner P; Bayani J; Squire JA
    Genes Chromosomes Cancer; 1997 Nov; 20(3):243-52. PubMed ID: 9365831
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MYCN amplification and 17q in neuroblastoma: evidence for structural association.
    O'Neill S; Ekstrom L; Lastowska M; Roberts P; Brodeur GM; Kees UR; Schwab M; Bown N
    Genes Chromosomes Cancer; 2001 Jan; 30(1):87-90. PubMed ID: 11107180
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship of DDX1 and NAG gene amplification/overexpression to the prognosis of patients with MYCN-amplified neuroblastoma.
    Kaneko S; Ohira M; Nakamura Y; Isogai E; Nakagawara A; Kaneko M
    J Cancer Res Clin Oncol; 2007 Mar; 133(3):185-92. PubMed ID: 17028906
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Concomitant DDX1 and MYCN gain in neuroblastoma.
    Defferrari R; Tonini GP; Conte M; Papio F; Sementa AR; Valent A; Schena F; Perri P; Mazzocco K
    Cancer Lett; 2007 Oct; 256(1):56-63. PubMed ID: 17611020
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of genetic changes in rat endometrial carcinomas by means of comparative genomic hybridization.
    Helou K; Walentinsson A; Beckmann B; Johansson A; Hedrich HJ; Szpirer C; Klinga-Levan K; Levan G
    Cancer Genet Cytogenet; 2001 Jun; 127(2):118-27. PubMed ID: 11425450
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amplification of N-myc and ornithine decarboxylase genes in human neuroblastoma and hydroxyurea-resistant hamster cell lines.
    Tonin PN; Yeger H; Stallings RL; Srinivasan PR; Lewis WH
    Oncogene; 1989 Sep; 4(9):1117-21. PubMed ID: 2780050
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recurrent gene amplifications in human type I endometrial adenocarcinoma detected by fluorescence in situ hybridization.
    Samuelson E; Levan K; Adamovic T; Levan G; Horvath G
    Cancer Genet Cytogenet; 2008 Feb; 181(1):25-30. PubMed ID: 18262049
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.